Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Pharmacol Biochem Behav ; 202: 173118, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33497715

RESUMO

BACKGROUND: Smoking mixtures containing synthetic cannabinoids (SCs) have become very popular over the last years but pose a serious risk for public health. Limited knowledge is, however, available regarding the acute effects of SCs on cognition and psychomotor performance. Earlier we demonstrated signs of impairment in healthy volunteers after administering one of the first SCs, JWH-018, even though subjective intoxication was low. In the current study, we aimed to investigate the acute effects of JWH-018 on several cognitive and psychomotor tasks in participants who are demonstrating representative levels of acute intoxication. METHODS: 24 healthy cannabis-experienced participants took part in this placebo-controlled, cross-over study. Participants inhaled the vapor of 75 µg JWH-018/kg body weight and were given a booster dose if needed to induce a minimum level of subjective high. They were subsequently monitored for 4 h, during which psychomotor and cognitive performance, vital signs, and subjective experience were measured, and serum concentrations were determined. RESULTS: Maximum subjective high (average 64%) was reached 30 min after administration of JWH-018, while the maximum blood concentration was shown after 5 min (8 ng/mL). JWH-018 impaired motor coordination (CTT), attention (DAT and SST), memory (SMT), it lowered speed-accuracy efficiency (MFFT) and slowed down response speed (DAT). CONCLUSION: In accordance with our previous studies, we demonstrated acute psychomotor and cognitive effects of a relatively low dose of JWH-018.


Assuntos
Canabinoides/toxicidade , Cannabis/química , Disfunção Cognitiva/induzido quimicamente , Drogas Ilícitas/toxicidade , Indóis/toxicidade , Naftalenos/toxicidade , Extratos Vegetais/toxicidade , Transtornos Psicomotores/induzido quimicamente , Uso Recreativo de Drogas/psicologia , Medicamentos Sintéticos/toxicidade , Administração por Inalação , Adulto , Atenção/efeitos dos fármacos , Canabinoides/administração & dosagem , Canabinoides/sangue , Cognição/efeitos dos fármacos , Disfunção Cognitiva/sangue , Estudos Cross-Over , Método Duplo-Cego , Feminino , Voluntários Saudáveis , Humanos , Drogas Ilícitas/sangue , Indóis/administração & dosagem , Indóis/sangue , Masculino , Naftalenos/administração & dosagem , Naftalenos/sangue , Extratos Vegetais/administração & dosagem , Extratos Vegetais/sangue , Transtornos Psicomotores/sangue , Desempenho Psicomotor/efeitos dos fármacos , Tempo de Reação/efeitos dos fármacos , Memória Espacial/efeitos dos fármacos , Medicamentos Sintéticos/administração & dosagem , Adulto Jovem
2.
Anal Chim Acta ; 1063: 110-116, 2019 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-30967174

RESUMO

BACKGROUND: Hyphenation of liquid chromatography (LC) with high-resolution mass spectrometry (HRMS) offers the potential to develop broad-spectrum screening procedures from low volumes of biological matrices. In parallel, dried blood spot (DBS) has become a valuable tool in the bioanalysis landscape to overcome conventional blood collection issues. Herein, we demonstrated the applicability of DBS as micro-sampling procedure for broad-spectrum toxicological screening. METHODS: A method was developed on a HRMS system in data dependant acquisition (DDA) mode using an extensive inclusion list to promote collection of relevant data. 104 real toxicology cases were analysed, and the results were cross-validated with one published and one commercial screening procedures. Quantitative MRM analyses were also performed on identified substances on a triple quadrupole instrument as a complementary confirmation procedure. RESULTS: The method showed limits of identification (LOIs) in appropriateness with therapeutic ranges for all the classes of interest. Applying the three screening approaches on 104 real cases, 271 identifications were performed including 14 and 6 classes of prescribed and illicit drugs, respectively. Among the detected substances, 23% were only detected by the proposed method. Based on confirmatory analyses, we demonstrated that the use of blood micro-samples did not impair the sensitivity allowing more identifications in the low concentration ranges. CONCLUSION: A LC-HRMS assay was successfully developed for toxicological screening of blood microsamples demonstrating a high identification power at low concentration ranges. The validation procedure and the analysis of real cases demonstrated the potential of this assay by supplementing screening approaches of reference.


Assuntos
Teste em Amostras de Sangue Seco , Avaliação Pré-Clínica de Medicamentos/instrumentação , Avaliação Pré-Clínica de Medicamentos/métodos , Drogas Ilícitas/sangue , Cromatografia Líquida , Humanos , Espectrometria de Massas em Tandem
3.
Clin Chim Acta ; 488: 196-201, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30439354

RESUMO

Stability data of toxics or drugs in gel-based or mechanical separation blood collection tubes are lacking, especially for therapeutic drug monitoring and clinical toxicology procedures. According to ISO 15189 accreditation standard, laboratories need to master the entire preanalytical process including the stability of analytes in a specific tube. Here we explored the impact of BD PST™ II and Barricor™ separator tubes on the stability of 167 therapeutic compounds and common drugs of abuse in plasma samples using LC-MS/MS. Forty drugs were significantly affected by the use of PST™ II tubes, including antidepressants (11/26), neuroleptics (9/13), cardiovascular drugs (5/26), anxiolytics and hypnotics (4/25) and some drugs of abuse (5/26). Six compounds exhibited significant reduction by the mechanical Barricor™ tubes. Ten drugs exhibited low (<85%) but non-significant recoveries due to inter-assay variability. Besides, a logP > 3.3 was determined as a cut-off value to predict a potential lack of stability in PST™ II gel tubes with an 86.4% sensitivity and a 61.4% specificity. As a consequence, determination of drugs with a logP > 3.3 should be carried out with caution in plasma samples withdrawn on PST™ II. The study showed the Barricor™ and non-gel tubes cause less drug interference and are recommended for the drugs studied.


Assuntos
Ansiolíticos/sangue , Antidepressivos/sangue , Coleta de Amostras Sanguíneas , Fármacos Cardiovasculares/sangue , Hipnóticos e Sedativos/sangue , Drogas Ilícitas/sangue , Coleta de Amostras Sanguíneas/normas , Cromatografia Líquida , Avaliação Pré-Clínica de Medicamentos , Monitoramento de Medicamentos , Géis/química , Humanos , Espectrometria de Massas em Tandem
4.
Toxicology ; 376: 75-82, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-27234315

RESUMO

In recent years it was verified there are an alarming growing number of teenagers and young adults using a combination of dietary supplements (DS) anabolic androgenic steroids (AAS) and drugs of abuse. This practice is used to improve physical fitness and appearance, may cause serious side effects. This article shows the alterations in the hematological and renal function parameters associate with these substances in 40 athletes. This research involved three steps: 1-the administration of a self-completion questionnaire ; 2-the assessment of hematological and biochemical parameters of renal function and; 3-toxicological urinalysis. Hematological and biochemical tests were conducted in an accredited laboratory and the toxicological urinalysis was validated in our laboratory using liquid-liquid extraction (LLE) and gas chromatography-mass spectrometry (GC-MS). The testosterone levels in the participants who consumed steroids increased 20-60% and alterations in serum creatinine, urea and uric reached values of up to 1.9; 60.6 and 7.5mg/dL, respectively. The toxicological urinalysis supports self-reports confirming the use of AAS and recreational drugs, putting at risk the health of those athletes increasing the chances of kidney diseases.


Assuntos
Atletas , Suplementos Nutricionais , Drogas Ilícitas/sangue , Drogas Ilícitas/urina , Congêneres da Testosterona/sangue , Congêneres da Testosterona/urina , Adulto , Compreensão , Dopagem Esportivo/métodos , Cromatografia Gasosa-Espectrometria de Massas/métodos , Humanos , Masculino , Inquéritos e Questionários , Urinálise/métodos , Adulto Jovem
5.
Addiction ; 108(3): 534-44, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22971158

RESUMO

AIMS: Recently, several synthetic cannabinoids were identified in herbal mixtures consumed as recreational drugs alternative to cannabis products. The aim was to characterize the acute toxicity of synthetic cannabinoids as experienced by emergency patients. DESIGN: This was a retrospective study targeting patients seeking emergency treatment after recreational use of synthetic cannabinoids. SETTING AND PARTICIPANTS: Patients were selected from the database of the Poisons Information Center Freiburg between September 2008 and February 2011. The inclusion criteria were: hospitalization, available clinical reports and analytical verification of synthetic cannabinoid uptake. In total, 29 patients were included (age 14-30 years, median 19; 25 males, four females). MEASUREMENTS: Clinical reports were evaluated and synthetic cannabinoids and other drugs were determined analytically. FINDINGS: CP-47,497-C8 (one), JWH-015 (one), JWH-018 (eight), JWH-073 (one), JWH-081 (seven), JWH-122 (11), JWH-210 (11), JWH-250 (four) and AM 694 (one) were quantified in blood samples. JWH-018 was most common in 2008-9, JWH-122 in 2010, and JWH-210 in 2011. Tachycardia, agitation, hallucination, hypertension, minor elevation of blood glucose, hypokalaemia and vomiting were reported most frequently. Chest pain, seizures, myoclonia and acute psychosis were also noted. CONCLUSIONS: There appears to have been an increase in use of the extremely potent synthetic cannabinoids JWH-122 and JWH-210. Acute toxic symptoms associated with their use are also reported after intake of high doses of cannabis, but agitation, seizures, hypertension, emesis and hypokalaemia seem to be characteristic to the synthetic cannabinoids, which are high-affinity and high-efficacy agonists of the CB(1) receptor. Thus, these effects are due probably to a strong CB(1) receptor stimulation.


Assuntos
Canabinoides/intoxicação , Drogas Ilícitas/intoxicação , Preparações de Plantas/intoxicação , Adolescente , Adulto , Canabinoides/sangue , Tratamento de Emergência/estatística & dados numéricos , Feminino , Humanos , Drogas Ilícitas/sangue , Masculino , Preparações de Plantas/sangue , Estudos Retrospectivos , Detecção do Abuso de Substâncias/métodos , Adulto Jovem
6.
J Chromatogr B Analyt Technol Biomed Life Sci ; 879(25): 2519-26, 2011 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-21803006

RESUMO

Prohibition of some synthetic cannabimimetics (e.g., JWH-018, JWH-073 and CP 47497) in a number of countries has led to a rise in new compounds in herbal mixtures that create marijuana-like psychotropic effects when smoked. The cannabimimetic JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole) was identified in May 2009 by the German Federal Criminal Police as an new ingredient in herbal smoking mixtures. The absence or low presence of the native compound in urine samples collected from persons who had consumed JWH-250 necessitates a detailed identification of their metabolites, which are excreted with urine and present in blood. Using gas and liquid chromatography-mass spectrometry (GC-MS and LC-MS/MS), we identified a series of metabolites in urine samples and serum sample from humans and urine samples from rats that were products of the following reactions: (a) mono- and dihydroxylation of aromatic and aliphatic residues of the parent compound, (b) trihydroxylation and dehydration of the N-alkyl chain, (c) N-dealkylation and (d) N-dealkylation and monohydroxylation. The prevailing urinary metabolites in humans were the monohydroxylated forms, while N-dealkylated and N-dealkyl monohydroxylated forms were found in rats. The detection of the mono- and dihydroxylated metabolites of JWH-250 in urine and serum samples by GC-MS and LC-MS/MS proved to be effective in determining consumption of this drug.


Assuntos
Cromatografia Líquida/métodos , Cromatografia Gasosa-Espectrometria de Massas/métodos , Drogas Ilícitas/metabolismo , Indóis/metabolismo , Fumar/metabolismo , Animais , Canabinoides , Humanos , Hidroxilação , Drogas Ilícitas/sangue , Drogas Ilícitas/urina , Indóis/sangue , Indóis/urina , Extratos Vegetais/sangue , Extratos Vegetais/metabolismo , Extratos Vegetais/urina , Psicotrópicos/sangue , Psicotrópicos/metabolismo , Psicotrópicos/urina , Ratos , Fumar/sangue , Fumar/urina
7.
Hum Psychopharmacol ; 26(3): 224-36, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21671456

RESUMO

OBJECTIVE: This study aimed to evaluate the abuse potential and cognitive effects of nabiximols (Sativex, GW Pharma Ltd. Salisbury, UK), an oromucosal spray primarily containing delta­9­tetrahydrocannabinol (THC) and cannabidiol (CBD). METHODS: This was a single­dose, randomized, double­blind, crossover study comparing nabiximols (4, 8, and 16 consecutive sprays: 10.8, 21.6, and 43.2 mg THC, respectively) with dronabinol 20 and 40 mg (synthetic THC: Marinol, Solvay Pharmaceuticals, Brussels, Belgium) and matching placebos in 23 recreational cannabis users. Subjective and cognitive/psychomotor measures were administered over 24 h post­dose. RESULTS: Dronabinol was significantly different from placebo on abuse potential measures, thereby confirming study validity. Nabiximols 10.8 mg was not significantly different from placebo on primary measures but was different on some secondary measures. Nabiximols 21.6 mg was significantly greater than placebo on some primary/secondary measures, whereas nabiximols 43.2 mg showed significant effects on most measures. Nabiximols 10.8 mg was significantly lower than dronabinol doses on most measures ( p < 0.05). Dronabinol 20 mg effects were numerically higher than nabiximols 21.6 mg but were statistically significant only for some measures. Dronabinol 40 mg and nabiximols 43.2 mg were generally not statistically different. CONCLUSIONS: Both dronabinol and nabiximols had significant abuse potential compared with placebo at higher doses. Nabiximols showed similar or slightly less abuse potential compared with dronabinol. Therefore, the abuse potential of nabiximols should be no higher than that of dronabinol.


Assuntos
Canabinoides/administração & dosagem , Cognição/efeitos dos fármacos , Dronabinol/administração & dosagem , Abuso de Maconha , Mucosa Bucal/efeitos dos fármacos , Extratos Vegetais/administração & dosagem , Adulto , Canabidiol , Canabinoides/sangue , Cognição/fisiologia , Estudos Cross-Over , Método Duplo-Cego , Dronabinol/sangue , Combinação de Medicamentos , Avaliação de Medicamentos/métodos , Feminino , Humanos , Drogas Ilícitas/sangue , Masculino , Abuso de Maconha/sangue , Abuso de Maconha/epidemiologia , Pessoa de Meia-Idade , Mucosa Bucal/fisiologia , Sprays Orais , Extratos Vegetais/sangue , Adulto Jovem
8.
Am J Emerg Med ; 29(3): 319-32, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20825811

RESUMO

γ-Hydroxybutyrate (GHB) and its prodrugs are drugs of abuse that were also sold as "dietary supplements." Users present to emergency departments with overdose, impaired driving, withdrawal, and associated trauma. We compiled a series of GHB-associated deaths to elucidate lethal risks, GHB concentrations, cointoxicants, products, uses, and medical interventions. Death records were reviewed for toxicology, autopsy findings, and history. Inclusion cutoffs were as follows: 5/10 mg/L of GHB (antemortem blood/urine) and 50/20/7 mg/L of GHB (postmortem blood/urine/vitreous). Of 226 deaths included, 213 had cardiorespiratory arrest and 13 had fatal accidents. Seventy-eight deaths (35%) had no cointoxicants. Sixteen deaths involved "supplements" and 1 involved pharmaceutical GHB (Xyrem, Jazz Pharmaceuticals, Palo Alto, CA). Postmortem blood GHB was 18 to 4400 mg/L (median, 347 mg/L) in deaths negative for cointoxicants. Cardiorespiratory arrest occurred prehospital in 100% of 184 cases with available history. Of 72 cases with antemortem adverse effects reported, medical assistance was delayed or absent in 66; of these, acute GHB ingestion was known in 51, including 40 left to "sleep off" adverse effects. Thirty others were left "sleeping" and found dead. γ-Hydroxybutyrate is lethal even without cointoxicants, directly and through fatal accidents. Medical interventions were frequently delayed or absent despite known GHB ingestion, and witnessed adverse events and cardiorespiratory arrest occurred prehospital. Education is needed about the lethality of GHB and the necessity for prompt medical intervention.


Assuntos
Drogas Ilícitas/intoxicação , Oxibato de Sódio/intoxicação , Transtornos Relacionados ao Uso de Substâncias/mortalidade , Adolescente , Adulto , Feminino , Humanos , Drogas Ilícitas/sangue , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Oxibato de Sódio/sangue , Estados Unidos , Adulto Jovem
9.
Anal Bioanal Chem ; 396(7): 2403-14, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20069283

RESUMO

Since the late 1990s and early 2000s, derivatives of well-known designer drugs as well as new psychoactive compounds have been sold on the illicit drug market and have led to intoxications and fatalities. The LC-MS/MS screening method presented covers 31 new designer drugs as well as cathinone, methcathinone, phencyclidine, and ketamine which were included to complete the screening spectrum. All but the last two are modified molecular structures of amphetamine, tryptamine, or piperazine. Among the amphetamine derivatives are cathinone, methcathinone, 3,4-DMA, 2,5-DMA, DOB, DOET, DOM, ethylamphetamine, MDDMA, 4-MTA, PMA, PMMA, 3,4,5-TMA, TMA-6 and members of the 2C group: 2C-B, 2C-D, 2C-H, 2C-I, 2C-P, 2C-T-2, 2C-T-4, and 2C-T-7. AMT, DPT, DiPT, MiPT, DMT, and 5MeO-DMT are contained in the tryptamine group, BZP, MDBP, TFMPP, mCPP, and MeOPP in the piperazine group. Using an Applied Biosystems LC-MS/MS API 365 TurboIonSpray it is possible to identify all 35 substances. After addition of internal standards and mixed-mode solid-phase extraction the analytes are separated using a Synergi Polar RP column and gradient elution with 1 mM ammonium formate and methanol/0.1% formic acid as mobile phases A and B. Data acquisition is performed in MRM mode with positive electro spray ionization. The assay is selective for all tested substances. Limits of detection were determined by analyzing S/N-ratios and are between 1.0 and 5.0 ng/mL. Matrix effects lie between 65% and 118%, extraction efficiencies range from 72% to 90%.


Assuntos
Anfetaminas/sangue , Cromatografia Líquida/métodos , Drogas Desenhadas/análise , Avaliação Pré-Clínica de Medicamentos/métodos , Espectrometria de Massas/métodos , Piperazinas/sangue , Triptaminas/sangue , Análise Química do Sangue/métodos , Misturas Complexas/sangue , Humanos , Drogas Ilícitas/sangue , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
10.
Anal Bioanal Chem ; 393(1): 97-107, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18759106

RESUMO

Driving under the influence of prescribed or illegal drugs increases the risk of having road accidents, just like driving under the influence of alcohol. In forensic toxicology, an increasing number of blood samples must be analyzed for drugs. Immunoassays tailored for a limited number of drugs (of abuse) are usually applied as prescreening tests at the roadside and/or in the laboratory. However, many other common drugs, such as anesthetics, antidepressants, antiepileptics, antihistamines, newer designer drugs, herbal drugs, neuroleptics (antipsychotics), opioids, or sedative-hypnotics, can also impair drivers. Therefore, this paper reviews multianalyte single-stage and tandem gas or liquid chromatography-mass spectrometry (GC-MS or LC-MS) procedures for the screening, identification, and validated quantification of such drugs in blood that have been reported since 2003. Basic information about the biosample assayed, workup, chromatography, the mass spectral detection mode, and validation data is summarized in tables. The pros and cons of the reviewed procedures are critically discussed, particularly with respect to their probable usefulness in impaired driving toxicology.


Assuntos
Acidentes de Trânsito , Espectrometria de Massas/métodos , Medicamentos sob Prescrição/análise , Detecção do Abuso de Substâncias/métodos , Cromatografia Líquida , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Drogas Ilícitas/sangue
11.
Am J Forensic Med Pathol ; 29(1): 27-31, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19749613

RESUMO

Deaths from 1992 through 2003 related to sauna bathing in Sweden were collected from a national computer data base comprising all medicolegal autopsies, generating 77 cases included in this study. Of all deaths, 82% were men, most of them middle-aged. The geographic distribution seemed to be roughly related to the population density. Most bathers died on a weekend, and 84% were found dead in a sauna. In 69 cases, the blood alcohol concentration was determined; 49 (71%) of these tested positive, often with high concentrations. In 65 cases, a major disease/state that could explain death was identified; 34 (44%) of these deaths were related to alcohol and 18 (23%) cardiovascular. Other causes of death were drowning, CO poisoning, O2 deprivation, amphetamine intoxication, and burn injuries. In 13 cases, the cause of death remained undetermined. The results indicate that sauna habits in Sweden are similar to those in Finland but probably less common. The most important risk group is middle-aged men, especially those with heavy alcohol consumption. Among the cases found dead in a sauna, all but 2 were found alone. Obviously, bathing alone is a risk factor that can easily be avoided and should perhaps be emphasized more.


Assuntos
Banho a Vapor/efeitos adversos , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Transtornos Relacionados ao Uso de Anfetaminas/mortalidade , Queimaduras/mortalidade , Intoxicação por Monóxido de Carbono/mortalidade , Depressores do Sistema Nervoso Central/sangue , Doença da Artéria Coronariana/patologia , Afogamento/mortalidade , Afogamento/patologia , Etanol/sangue , Feminino , Patologia Legal , Doenças das Valvas Cardíacas/patologia , Humanos , Hipóxia/mortalidade , Drogas Ilícitas/sangue , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/patologia , Miocárdio/patologia , Tamanho do Órgão , Distribuição por Sexo , Suécia/epidemiologia
12.
J Chromatogr B Biomed Sci Appl ; 734(1): 83-9, 1999 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-10574193

RESUMO

Organic nitrites have been used therapeutically for the treatment of angina pectoris and as diagnostic agents for the evaluation of cardiac heart murmurs. In addition, these highly volatile vasodilators are being used as inhalant drugs of abuse. We developed a gas chromatographic assay using electron capture detection for the analysis of a representative nitrite inhalant, isobutyl nitrite (ISBN), in rat and human whole blood. Unconventional sampling and processing techniques were required because of the high volatility and chemical instability of nitrites in biological fluids. Our method produced a mean recovery of ISBN from rat blood of about 86% over a concentration range of 1.0 to 400 ng/ml. The inter-day coefficient of variation was below 15% at the lowest quantifiable concentration of 1 ng/ml ISBN in rat blood. In this report, we applied the analytical method to obtain new pharmacokinetic information about ISBN. Results show that rats inhaling 900 ppm ISBN for 45 min produced steady-state blood concentrations of about 290 ng/ml, and a rapid elimination half-life of 1.4 min.


Assuntos
Drogas Ilícitas/sangue , Drogas Ilícitas/farmacocinética , Nitritos/sangue , Nitritos/farmacocinética , Administração por Inalação , Animais , Coleta de Amostras Sanguíneas/métodos , Soluções Tampão , Cromatografia Gasosa , Dimetil Sulfóxido , Estabilidade de Medicamentos , Meia-Vida , Humanos , Masculino , Nitritos/administração & dosagem , Fosfatos , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA